X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (22) 22
index medicus (21) 21
humans (18) 18
cancer (15) 15
tumors (15) 15
middle aged (13) 13
chemotherapy (12) 12
female (12) 12
male (12) 12
aged (11) 11
immunotherapy (10) 10
analysis (9) 9
care and treatment (9) 9
adult (8) 8
antineoplastic agents - therapeutic use (8) 8
lung cancer (8) 8
aged, 80 and over (7) 7
carcinoma (7) 7
dendritic cells (7) 7
immunology (7) 7
medical prognosis (7) 7
melanoma (7) 7
metastasis (7) 7
patients (7) 7
survival (7) 7
biomarkers (6) 6
cancer therapies (6) 6
expression (6) 6
mice (6) 6
research (6) 6
therapy (6) 6
treatment outcome (6) 6
abridged index medicus (5) 5
animals (5) 5
antimitotic agents (5) 5
antineoplastic agents (5) 5
cell line, tumor (5) 5
clinical trials (5) 5
lymphocytes (5) 5
monoclonal antibodies (5) 5
mutation (5) 5
research article (5) 5
t cells (5) 5
antineoplastic agents - adverse effects (4) 4
apoptosis (4) 4
colon cancer (4) 4
cytotoxicity (4) 4
drug administration schedule (4) 4
gene expression (4) 4
gene therapy (4) 4
liver (4) 4
multidisciplinary sciences (4) 4
nivolumab (4) 4
proteins (4) 4
resistance (4) 4
surgery (4) 4
toxicity (4) 4
tumor (4) 4
usage (4) 4
adenocarcinoma (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
antitumor immunity (3) 3
biology (3) 3
biomarkers, tumor - blood (3) 3
bladder cancer (3) 3
blockade (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
clear cell-type renal cell carcinoma (3) 3
colorectal cancer (3) 3
cytokines (3) 3
dendritic cells - immunology (3) 3
disease-free survival (3) 3
double-blind (3) 3
effectiveness (3) 3
gastroenterology & hepatology (3) 3
genes (3) 3
genetic aspects (3) 3
growth-factor (3) 3
immune system (3) 3
immunity (3) 3
internal medicine (3) 3
laboratories (3) 3
lung neoplasms - drug therapy (3) 3
lung neoplasms - pathology (3) 3
lung-cancer (3) 3
lymphocytes t (3) 3
medical colleges (3) 3
medicine (3) 3
medicine, general & internal (3) 3
medicine, research & experimental (3) 3
metastases (3) 3
neoplasm metastasis (3) 3
pathology (3) 3
prognosis (3) 3
science (3) 3
t cell receptors (3) 3
tumor-necrosis-factor (3) 3
urologic neoplasms - drug therapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1540 - 1550
Summary Background Despite recent advances in the treatment of advanced non-small-cell lung cancer, there remains a need for effective treatments for... 
Internal Medicine | CRITERIA | MEDICINE, GENERAL & INTERNAL | ANTI-PD-L1 ANTIBODY | THERAPY | NSCLC | IMMUNOTHERAPY | PD-L1 | BLOCKADE | NIVOLUMAB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - chemistry | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Patient Selection | Taxoids - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Agents - adverse effects | Adult | Female | Taxoids - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Lung Neoplasms - chemistry | Docetaxel | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Taxoids - administration & dosage | Aged | B7-H1 Antigen - analysis | Carcinoma, Non-Small-Cell Lung - drug therapy | Antimitotic agents | Medical colleges | Lung cancer, Non-small cell | Antineoplastic agents | Analysis | Chemotherapy | Biopsy | Genes | Lung cancer | Clinical trials | Oncology | Mutation | Tumors | Slopes | Cell survival | Medical treatment | Medical services | FDA approval | Survival | Patients | Medical centres | Pembrolizumab | Randomization | Interactive systems | Immunotherapy | Risk assessment | PD-L1 protein | Biomarkers
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 4, pp. 350 - 357
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 672,681a - 681,681a
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10031, pp. 1909 - 1920
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 67 - 76
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e86263
Purpose: To identify tissue microRNAs predictive of sunitinib activity in patients with metastatic renal-cell-carcinoma (MRCC) and to evaluate in vitro their... 
SURVIVAL | INTERFERON | CANCER-PATIENTS | ASSOCIATIONS | 1ST-LINE SUNITINIB | MULTIDISCIPLINARY SCIENCES | MATRIX-METALLOPROTEINASE-9 | TARGETS | SELECTION | EXPRESSION | PROGRESSION | Kidney Neoplasms - genetics | Prognosis | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Vascular Endothelial Growth Factor A - secretion | Neoplasm Metastasis | Aged, 80 and over | Adult | Female | Indoles - pharmacology | Matrix Metalloproteinase 9 - secretion | Antineoplastic Agents - pharmacology | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Reproducibility of Results | Paracrine Communication | Carcinoma, Renal Cell - pathology | Treatment Outcome | Kidney Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Drug Resistance, Neoplasm - genetics | Pyrroles - pharmacology | Models, Biological | Cell Line, Tumor | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | MicroRNAs - genetics | Kidney Neoplasms - drug therapy | Antimitotic agents | Care and treatment | MicroRNA | Carcinoma | Analysis | Metastasis | Antineoplastic agents | Vascular endothelial growth factor | Cancer | Cell survival | Effectiveness | Secretion | MiRNA | Paracrine signalling | Oncology | Gene expression | Cancer therapies | Patients | Gelatinase B | Metastases | MicroRNAs | Medical prognosis | Predictions | Biomarkers | Prostate cancer | Bioinformatics | Cell migration | Clear cell-type renal cell carcinoma | Tumors | Kidney transplantation | Phenotype | RNA | Fenotip | Renal cancer | Càncer de ronyó | Resistència als medicaments | Marcadors bioquímics | Micro RNAs | Drug resistance | Biochemical markers
Journal Article
International Journal of Cancer, ISSN 0020-7136, 10/2019, Volume 145, Issue 7, pp. 1991 - 2001
Journal Article